메뉴 건너뛰기




Volumn 56, Issue 4, 2008, Pages 765-767

Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

EID: 41549116849     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01612.x     Document Type: Letter
Times cited : (21)

References (8)
  • 1
    • 0024235550 scopus 로고
    • Three treatment approaches and clinical factors in the reduction of drooling
    • Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988 3 : 73 78.
    • (1988) Dysphagia , vol.3 , pp. 73-78
    • Thomas-Stonell, N.1    Greenberg, J.2
  • 2
    • 0033974106 scopus 로고    scopus 로고
    • Botulinum toxin a as treatment for drooling saliva in PD
    • Pal PK, Calne DB, Calne S et al. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000 54 : 244 247.
    • (2000) Neurology , vol.54 , pp. 244-247
    • Pal, P.K.1    Calne, D.B.2    Calne, S.3
  • 3
    • 0242662829 scopus 로고    scopus 로고
    • A randomized trial of botulinum toxin a for treatment of drooling
    • Lipp A, Trottenberg T, Schink T et al. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003 61 : 1279 1281.
    • (2003) Neurology , vol.61 , pp. 1279-1281
    • Lipp, A.1    Trottenberg, T.2    Schink, T.3
  • 4
    • 0038422869 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type a in the treatment of drooling in Parkinsonism
    • Mancini F, Zangaglia R, Cristina S et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in Parkinsonism. Mov Disord 2003 18 : 685 688.
    • (2003) Mov Disord , vol.18 , pp. 685-688
    • Mancini, F.1    Zangaglia, R.2    Cristina, S.3
  • 5
    • 0035059822 scopus 로고    scopus 로고
    • Treatment of sialorrhoea with ultrasound guided botulinum toxin type a injection in patients with neurological disorders
    • Porta M, Gamba M, Bertacchi G et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001 704 : 538 540.
    • (2001) J Neurol Neurosurg Psychiatry , vol.704 , pp. 538-540
    • Porta, M.1    Gamba, M.2    Bertacchi, G.3
  • 6
    • 0032937059 scopus 로고    scopus 로고
    • Diagnostic criteria for Parkinson disease
    • Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999 56 : 33 39.
    • (1999) Arch Neurol , vol.56 , pp. 33-39
    • Gelb, D.J.1    Oliver, E.2    Gilman, S.3
  • 7
    • 0345830743 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease
    • Ondo WG, Hunter C, Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 2004 62 : 37 40.
    • (2004) Neurology , vol.62 , pp. 37-40
    • Ondo, W.G.1    Hunter, C.2    Moore, W.3
  • 8
    • 34347331288 scopus 로고    scopus 로고
    • Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease
    • Contarino MF, Pompili M, Tittoto P et al. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. Parkinsonism Relat Disord 2007 13 : 299 303.
    • (2007) Parkinsonism Relat Disord , vol.13 , pp. 299-303
    • Contarino, M.F.1    Pompili, M.2    Tittoto, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.